Collegium Pharmaceutical, Inc (NASDAQ: COLL), Stoughton, MA – FDA Inspections
Inspection records and compliance data for Collegium Pharmaceutical, Inc in Stoughton, Massachusetts. 3 FDA inspections on record, last inspected March 15, 2019. Publicly traded as NASDAQ: COLL.
This profile covers Collegium Pharmaceutical, Inc based in Stoughton, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected October 23, 2008. Last inspected March 15, 2019.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 15, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1085723 |
| August 31, 2010 | NAI | Human Drugs, Medical Devices & Rad Health · Compliance: Devices | 679887 |
| October 23, 2008 | NAI | Human Drugs · Drug Quality Assurance | 546655 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Collegium Pharmaceutical, Inc
Stock ticker
COLL
Exchange
NASDAQ
Share price
$24.95
Market cap
$775.3M
Price as of
November 13, 2026
FEI Number
3005150234
Address
100 Technology Center Dr Ste 300, Stoughton, Massachusetts 02072, United States
Country
United States
ID: 4b463c1e-27ef-417a-949c-588341578889